lobbying_activities: 638242

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
638242	5689320d-6f6e-4c51-8a66-18a9f411c005	Q2	THE OB-C GROUP, LLC	29802	ELI LILLY	2008	second_quarter	PHA	HR 5629, Pathway for Biosimilars Act: biologics. S 1695, Biologics Price Competition and Innovation Act of 2007: biologics.	HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2008-07-18T12:10:21-04:00